PCM
PRVA icon

Peregrine Capital Management’s Privia Health PRVA Stock Holding History

Peregrine Capital Management’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.27M Buy
360,207
+43,489
+14% +$1.01M 0.3% 98
2026
Q1 		$6.51M Sell
316,718
-13,594
-4% -$306K 0.24% 125
2025
Q4 		$7.83M Sell
330,312
-4,247
-1% -$103K 0.24% 119
2025
Q3 		$8.33M Sell
334,559
-8,733
-3% -$188K 0.25% 108
2025
Q2 		$7.9M Buy
343,292
+13,162
+4% +$305K 0.24% 122
2025
Q1 		$7.41M Buy
330,130
+9,362
+3% +$218K 0.25% 116
2024
Q4 		$6.27M Buy
320,768
+5,759
+2% +$114K 0.19% 166
2024
Q3 		$5.74M Buy
315,009
+819
+0.3% +$15.6K 0.17% 191
2024
Q2 		$5.46M Buy
314,190
+32,311
+11% +$572K 0.16% 218
2024
Q1 		$5.52M Buy
281,879
+58,640
+26% +$1.24M 0.16% 222
2023
Q4 		$5.14M Sell
223,239
-66,975
-23% -$1.5M 0.15% 226
2023
Q3 		$6.67M Buy
290,214
+35,948
+14% +$914K 0.2% 205
2023
Q2 		$6.64M Buy
254,266
+68
+0% +$1.8K 0.18% 224
2023
Q1 		$7.02M Sell
254,198
-20,269
-7% -$535K 0.2% 215
2022
Q4 		$6.23M Buy
274,467
+63,942
+30% +$1.78M 0.2% 221
2022
Q3 		$7.17M Sell
210,525
-63,191
-23% -$2.34M 0.23% 201
2022
Q2 		$7.97M Sell
273,716
-30,839
-10% -$784K 0.24% 186
2022
Q1 		$8.14M Sell
304,555
-22,457
-7% -$530K 0.19% 213
2021
Q4 		$8.46M Buy
327,012
+9,416
+3% +$235K 0.17% 224
2021
Q3 		$7.48M Buy
317,596
+11,392
+4% +$398K 0.16% 233
2021
Q2 		$13.6M Buy
+306,204
New +$11.3M 0.24% 190

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Peregrine Capital Management's PRVA Position: Q2 2026 in Review

Peregrine Capital Management increased its Privia Health (PRVA) stake by 14% in Q2 2026, buying an estimated $1.01M and bringing the position to 360,207 shares worth $9.27M. The position accounts for 0.3% of the portfolio, ranked #98.

Peregrine Capital Management first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $13.6M in Q2 2021. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Peregrine Capital Management held 360,207 shares of Privia Health worth $9.27M as of Q2 2026.
  • Peregrine Capital Management bought 43,489 Privia Health shares in Q2 2026, an estimated $1.01M.
  • Privia Health made up 0.3% of Peregrine Capital Management's portfolio in Q2 2026, its #98 holding.
  • Peregrine Capital Management first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Peregrine Capital Management's Privia Health position peaked at $13.6M in Q2 2021.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.